We use cookies to improve your browsing experience on our website.
Please visit our Privacy Notice for more information about cookies and how we use them. We recommend that you accept the use of cookies for better navigation.

Incision Management

 

About Surgical Incision Management

Poor incision healing can lead to serious patient consequences such as surgical site infections (SSI), dehiscence, hematoma or seromas.


KCI provides advanced negative pressure therapies and post-operative dressings designed to help manage and protect closed surgical incisions.


Products described on this website (and associated product information), may not be available for sale in all markets as a result of local regulatory requirements. For information regarding product availability in your market, please contact your local Acelity/KCI representative here.

The Science Behind Our Products

KCI solutions are built on an extensive understanding of incision management, supported by a large body of clinical evidence

Why It Matters

Timely incision management can help reduce the human and economic costs of SSIs. Complications with incision healing lead to serious patient consequences.

  • There are 8.2 million people at risk for Surgical Site Infections (SSI)1
  • SSIs account for 21.8% of all healthcare-associated infections2
  • Of the top 5 Healthcare Acquired Infections (HAIs), SSIs account for 33.7% of the $9.8 billion cost to the healthcare system*1

 

*Top five HAIs are central line-associated bloodstream infections (CLABSI), ventilator-associated pneumonia (VAP), Clostridium difficile infection (C diff), surgical site infection and catheter-associated urinary tract infection (CAUTI).

Clinician Resources

KCI offers a wide range of clinically proven, economically beneficial incision management technologies for closed surgical incisions. These can contribute to positive outcomes for patients and healthcare professionals.

Clinical Evidences